Literature DB >> 21030553

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.

Andrew L Feldman1, Ahmet Dogan, David I Smith, Mark E Law, Stephen M Ansell, Sarah H Johnson, Julie C Porcher, Nazan Ozsan, Eric D Wieben, Bruce W Eckloff, George Vasmatzis.   

Abstract

The genetics of peripheral T-cell lymphomas are poorly understood. The most well-characterized abnormalities are translocations involving ALK, occurring in approximately half of anaplastic large cell lymphomas (ALCLs). To gain insight into the genetics of ALCLs lacking ALK translocations, we combined mate-pair DNA library construction, massively parallel ("Next Generation") sequencing, and a novel bioinformatic algorithm. We identified a balanced translocation disrupting the DUSP22 phosphatase gene on 6p25.3 and adjoining the FRA7H fragile site on 7q32.3 in a systemic ALK-negative ALCL. Using fluorescence in situ hybridization, we demonstrated that the t(6;7)(p25.3;q32.3) was recurrent in ALK-negative ALCLs. Furthermore, t(6;7)(p25.3;q32.3) was associated with down-regulation of DUSP22 and up-regulation of MIR29 microRNAs on 7q32.3. These findings represent the first recurrent translocation reported in ALK-negative ALCL and highlight the utility of massively parallel genomic sequencing to discover novel translocations in lymphoma and other cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030553      PMCID: PMC3035081          DOI: 10.1182/blood-2010-08-303305

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.

Authors:  Yajun Han; Hesham M Amin; Bevin Franko; Christine Frantz; Xinzhe Shi; Raymond Lai
Journal:  Blood       Date:  2006-07-06       Impact factor: 22.113

2.  Quantitating tissue specificity of human genes to facilitate biomarker discovery.

Authors:  George Vasmatzis; Eric W Klee; Dagmar M Kube; Terry M Therneau; Farhad Kosari
Journal:  Bioinformatics       Date:  2007-03-23       Impact factor: 6.937

3.  MicroRNA losses in the frequently deleted region of 7q in SMZL.

Authors:  E Ruiz-Ballesteros; M Mollejo; M Mateo; P Algara; P Martínez; M A Piris
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

Review 4.  Common fragile sites as targets for chromosome rearrangements.

Authors:  Martin F Arlt; Sandra G Durkin; Ryan L Ragland; Thomas W Glover
Journal:  DNA Repair (Amst)       Date:  2006-06-27

5.  Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation.

Authors:  Linfeng Chen; Przemyslaw Juszczynski; Kunihiko Takeyama; Ricardo C T Aguiar; Margaret A Shipp
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

6.  Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

Authors:  R D Gascoyne; P Aoun; D Wu; M Chhanabhai; B F Skinnider; T C Greiner; S W Morris; J M Connors; J M Vose; D S Viswanatha; A Coldman; D D Weisenburger
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

7.  Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.

Authors:  David A Wada; Mark E Law; Eric D Hsi; David J Dicaudo; Linglei Ma; Megan S Lim; Aieska de Souza; Nneka I Comfere; Roger H Weenig; William R Macon; Lori A Erickson; Nazan Ozsan; Stephen M Ansell; Ahmet Dogan; Andrew L Feldman
Journal:  Mod Pathol       Date:  2010-12-17       Impact factor: 7.842

8.  Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue.

Authors:  Leena Karenko; Sonja Hahtola; Suvi Päivinen; Ritva Karhu; Sanna Syrjä; Marketta Kähkönen; Boguslaw Nedoszytko; Soili Kytölä; Ying Zhou; Vesna Blazevic; Maria Pesonen; Hanna Nevala; Nina Nupponen; Harri Sihto; Inge Krebs; Annemarie Poustka; Jadwiga Roszkiewicz; Kalle Saksela; Pärt Peterson; Tapio Visakorpi; Annamari Ranki
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

9.  DUSP22/LMW-DSP2 regulates estrogen receptor-alpha-mediated signaling through dephosphorylation of Ser-118.

Authors:  Y Sekine; O Ikeda; Y Hayakawa; S Tsuji; S Imoto; N Aoki; K Sugiyama; T Matsuda
Journal:  Oncogene       Date:  2007-03-26       Impact factor: 9.867

10.  Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues.

Authors:  M G Narducci; E Pescarmona; C Lazzeri; S Signoretti; A M Lavinia; D Remotti; E Scala; C D Baroni; A Stoppacciaro; C M Croce; G Russo
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

View more
  85 in total

1.  Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.

Authors:  Xiaoming Xing; Thomas J Flotte; Mark E Law; Anthony J Blahnik; Wee-Joo Chng; Gaofeng Huang; Ryan A Knudson; Rhett P Ketterling; Julie C Porcher; Stephen M Ansell; Jagmohan Sidhu; Ahmet Dogan; Andrew L Feldman
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-09

Review 2.  Making a long story short: noncoding RNAs and chromosome change.

Authors:  J D Brown; S E Mitchell; R J O'Neill
Journal:  Heredity (Edinb)       Date:  2011-11-09       Impact factor: 3.821

Review 3.  Update: peripheral T-cell lymphomas.

Authors:  Kerry J Savage
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

Review 4.  ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.

Authors:  Ilske Oschlies; Jasmin Lisfeld; Laurence Lamant; Atsuko Nakazawa; Emanuele S G d'Amore; Ulrika Hansson; Konnie Hebeda; Ingrid Simonitsch-Klupp; Jadwiga Maldyk; Leonhard Müllauer; Marianne Tinguely; Markus Stücker; Marie-Cecile Ledeley; Reiner Siebert; Alfred Reiter; Laurence Brugières; Wolfram Klapper; Wilhelm Woessmann
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

5.  Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

Authors:  Rebecca L King; Linda N Dao; Ellen D McPhail; Elaine S Jaffe; Jonathan Said; Steven H Swerdlow; Christopher A Sattler; Rhett P Ketterling; Jagmohan S Sidhu; Eric D Hsi; Shridevi Karikehalli; Liuyan Jiang; Sarah E Gibson; Sarah L Ondrejka; Alina Nicolae; William R Macon; Surendra Dasari; Edgardo Parrilla Castellar; Andrew L Feldman
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

6.  Secondary cutaneous involvement by systemic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma with 6p25.3 rearrangement.

Authors:  Andrew L Feldman; Karen L Grogg; Ryan A Knudson; David J Inwards
Journal:  Histopathology       Date:  2015-06-19       Impact factor: 5.087

Review 7.  T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment.

Authors:  Carla Casulo; Owen O'Connor; Andrei Shustov; Michelle Fanale; Jonathan W Friedberg; John P Leonard; Brad S Kahl; Richard F Little; Lauren Pinter-Brown; Ranjani Advani; Steven Horwitz
Journal:  J Natl Cancer Inst       Date:  2016-12-31       Impact factor: 13.506

8.  Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.

Authors:  Xueju Wang; Rebecca L Boddicker; Surendra Dasari; Jagmohan S Sidhu; Marshall E Kadin; William R Macon; Stephen M Ansell; Rhett P Ketterling; Karen L Rech; Andrew L Feldman
Journal:  Hum Pathol       Date:  2017-01-30       Impact factor: 3.466

9.  Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing.

Authors:  Jess F Peterson; Kathryn E Pearce; Reid G Meyer; Patricia T Greipp; Ryan A Knudson; Linda B Baughn; Rhett P Ketterling; Andrew L Feldman
Journal:  Histopathology       Date:  2020-01-17       Impact factor: 5.087

Review 10.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.